180 related articles for article (PubMed ID: 31411244)
21. Thyrotropic activity of acidic isoelectric variants of human chorionic gonadotropin from trophoblastic tumors.
Mann K; Schneider N; Hoermann R
Endocrinology; 1986 Apr; 118(4):1558-66. PubMed ID: 3004921
[TBL] [Abstract][Full Text] [Related]
22. Clinical features of early-stage nonhydropic mole for diagnosis of persistent trophoblastic disease.
Miyoshi J; Ohba T; Fukunaga M; Katabuchi H
Obstet Gynecol; 2011 Oct; 118(4):847-53. PubMed ID: 21934448
[TBL] [Abstract][Full Text] [Related]
23. Do we need post-pregnancy screening with human chorionic gonadotrophin after previous hydatidiform mole to identify patients with recurrent gestational trophoblastic disease?
Earp KE; Hancock BW; Short D; Harvey RA; Fisher RA; Drew D; Sarwar N; Tidy JA; Winter MC; Chien P; Seckl MJ
Eur J Obstet Gynecol Reprod Biol; 2019 Mar; 234():117-119. PubMed ID: 30684876
[TBL] [Abstract][Full Text] [Related]
24. Hyperthyroidism and human chorionic gonadotrophin production in gestational trophoblastic disease.
Walkington L; Webster J; Hancock BW; Everard J; Coleman RE
Br J Cancer; 2011 May; 104(11):1665-9. PubMed ID: 21522146
[TBL] [Abstract][Full Text] [Related]
25. Clinical characteristics and thyroid function in complete hydatidiform mole complicated by hyperthyroidism.
Ramos MM; Maesta I; de Araújo Costa RA; Mazeto GMFS; Horowitz NS; Elias KM; Braga A; Berkowitz RS
Gynecol Oncol; 2022 Apr; 165(1):137-142. PubMed ID: 35153074
[TBL] [Abstract][Full Text] [Related]
26. What is the optimal duration of human chorionic gonadotrophin surveillance following evacuation of a molar pregnancy? A retrospective analysis on over 20,000 consecutive patients.
Coyle C; Short D; Jackson L; Sebire NJ; Kaur B; Harvey R; Savage PM; Seckl MJ
Gynecol Oncol; 2018 Feb; 148(2):254-257. PubMed ID: 29229282
[TBL] [Abstract][Full Text] [Related]
27. The current situation of health services for hydatidiform mole in Cambodia.
Yamamoto E; Kanal K; Soeung SC; Fujita N; Krang S; Long-Hay P; Nishino K; Niimi K; Hamajima N
J Obstet Gynaecol Res; 2021 Oct; 47(10):3652-3660. PubMed ID: 34342367
[TBL] [Abstract][Full Text] [Related]
28. Hyperthyroidism in molar pregnancy: β-HCG levels do not always reflect severity.
Chale-Matsau B; Mokoena S; Kemp T; Pillay TS
Clin Chim Acta; 2020 Dec; 511():24-27. PubMed ID: 32980362
[TBL] [Abstract][Full Text] [Related]
29. [Potential role of the angiogenic factor "EG-VEGF" in gestational trophoblastic diseases].
Boufettal H; Feige JJ; Benharouga M; Aboussaouira T; Nadifi S; Mahdaoui S; Samouh N; Alfaidy N
Pathol Biol (Paris); 2013 Oct; 61(5):178-83. PubMed ID: 23647696
[TBL] [Abstract][Full Text] [Related]
30. Serum Human Chorionic Gonadotropin Normogram for the Detection of Gestational Trophoblastic Neoplasia.
Eysbouts Y; Brouwer R; Ottevanger P; Massuger L; Sweep F; Thomas C; van Herwaarden A
Int J Gynecol Cancer; 2017 Jun; 27(5):1035-1041. PubMed ID: 28498241
[TBL] [Abstract][Full Text] [Related]
31. Thyroid function during pregnancy with special reference to hydatidiform mole and hyperemesis.
Bruun T; Kristoffersen K
Acta Endocrinol (Copenh); 1978 Jun; 88(2):383-9. PubMed ID: 78652
[TBL] [Abstract][Full Text] [Related]
32. [Twin pregnancy with complete hydatidiform mole].
Voloshchuk IN; Barinova IV; Kondrikov NI; Barto RA
Arkh Patol; 2017; 79(5):43-48. PubMed ID: 29027529
[TBL] [Abstract][Full Text] [Related]
33. [Expression and significance of LMP2 and PPM1A in gestational trophoblastic disease].
Zhang SS; Wan XY; Zhou CY; Lü WG; Xie X
Zhonghua Fu Chan Ke Za Zhi; 2011 Jul; 46(7):510-5. PubMed ID: 22041443
[TBL] [Abstract][Full Text] [Related]
34. Thyroid storm caused by a partial hydatidiform mole.
Chiniwala NU; Woolf PD; Bruno CP; Kaur S; Spector H; Yacono K
Thyroid; 2008 Apr; 18(4):479-81. PubMed ID: 18352822
[TBL] [Abstract][Full Text] [Related]
35. [Risk factors for gestational trophoblastic tumors following complete hydatidiform mole].
Grzybowski W; Płoszyński A; Mielnik J; Adamcio-Deptulska M; Preis K; Wojciechowska D
Ginekol Pol; 2002 Nov; 73(11):1003-10. PubMed ID: 12722390
[TBL] [Abstract][Full Text] [Related]
36. Gestational trophoblastic disease and associated factors among women experiencing first trimester pregnancy loss at a regional referral hospital in central Tanzania: a cross-sectional study.
Mdoe MB; Mwakigonja AR; Mwampagatwa I
Int Health; 2023 May; 15(3):250-257. PubMed ID: 35394041
[TBL] [Abstract][Full Text] [Related]
37. Experience of women on the Irish National Gestational Trophoblastic Disease Registry.
Joyce CM; Coulter J; Kenneally C; McCarthy TV; O'Donoghue K
Eur J Obstet Gynecol Reprod Biol; 2022 May; 272():206-212. PubMed ID: 35367922
[TBL] [Abstract][Full Text] [Related]
38. Term delivery of a complete hydatidiform mole with a coexisting living fetus followed by successful treatment of maternal metastatic gestational trophoblastic disease.
Peng HH; Huang KG; Chueh HY; Adlan AS; Chang SD; Lee CL
Taiwan J Obstet Gynecol; 2014 Sep; 53(3):397-400. PubMed ID: 25286799
[TBL] [Abstract][Full Text] [Related]
39. Pre-evacuation hCG glycoforms in uneventful complete hydatidiform mole and persistent trophoblastic disease.
Thomas CM; Kerkmeijer LG; Ariaens HJ; van der Steen RC; Massuger LF; Sweep FC
Gynecol Oncol; 2010 Apr; 117(1):47-52. PubMed ID: 20116088
[TBL] [Abstract][Full Text] [Related]
40. [T4, T3, T3 resin uptake, TBG and free T4 levels for thyroid functions in normal and molar pregnancy (author's transl)].
Murata K; Sugiyama Y
Nihon Sanka Fujinka Gakkai Zasshi; 1982 Mar; 34(3):292-8. PubMed ID: 6802912
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
